Company / Capital Returned to Shareholders
Neogen Capital Returned to Shareholders History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$3.1M
FY2021
5-year range
$3.1M / $3.1M
FY2019-FY2021
Trend
+0.0%
vs FY2020
Sector context
#94 of 108
Health Care
What the data says
Neogen's capital returned to shareholders of $3M is lower than 87% of companies in the Health Care sector (FY2021). Capital Returned to Shareholders remained relatively stable over the past 3 years, with values between $3M and $3M.
Based on SEC 10-K filings.
$3M in FY2021.
Remained stable around $3M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 108This company $3.1M Sector average $744.4M
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2021, capital returned to shareholders increased 0.0% year-over-year.
- Ranks #94 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $3.1M | +0.0% |
| FY2020 | $3.1M | +0.0% |
| FY2019 | $3.1M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026